SLC7A11 and neoplasm: This nanoparticle significantly augments ROS levels within tumor cells, inducing oxidative stress, and regulating P53 to downregulate SLC7A11 protein expression, thereby inhibiting the glutamate‐cystine antiporter system Xc‐ and stimulating ACSL4/LPCAT3 pathways.